Hologic Statistics
Total Valuation
Hologic has a market cap or net worth of $16.70 billion. The enterprise value is $16.85 billion.
| Market Cap | 16.70B |
| Enterprise Value | 16.85B |
Important Dates
The last earnings date was Thursday, January 29, 2026, after market close.
| Earnings Date | Jan 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Hologic has 223.24 million shares outstanding. The number of shares has decreased by -4.04% in one year.
| Current Share Class | 223.24M |
| Shares Outstanding | 223.24M |
| Shares Change (YoY) | -4.04% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 0.83% |
| Owned by Institutions (%) | 96.03% |
| Float | 221.21M |
Valuation Ratios
The trailing PE ratio is 31.13 and the forward PE ratio is 16.38. Hologic's PEG ratio is 2.05.
| PE Ratio | 31.13 |
| Forward PE | 16.38 |
| PS Ratio | 4.07 |
| Forward PS | 3.78 |
| PB Ratio | 3.18 |
| P/TBV Ratio | 15.87 |
| P/FCF Ratio | 17.45 |
| P/OCF Ratio | 15.21 |
| PEG Ratio | 2.05 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.48, with an EV/FCF ratio of 17.61.
| EV / Earnings | 30.99 |
| EV / Sales | 4.08 |
| EV / EBITDA | 12.48 |
| EV / EBIT | 15.82 |
| EV / FCF | 17.61 |
Financial Position
The company has a current ratio of 4.04, with a Debt / Equity ratio of 0.48.
| Current Ratio | 4.04 |
| Quick Ratio | 3.10 |
| Debt / Equity | 0.48 |
| Debt / EBITDA | 1.82 |
| Debt / FCF | 2.63 |
| Interest Coverage | 9.33 |
Financial Efficiency
Return on equity (ROE) is 10.86% and return on invested capital (ROIC) is 16.07%.
| Return on Equity (ROE) | 10.86% |
| Return on Assets (ROA) | 7.43% |
| Return on Invested Capital (ROIC) | 16.07% |
| Return on Capital Employed (ROCE) | 12.94% |
| Weighted Average Cost of Capital (WACC) | 7.68% |
| Revenue Per Employee | $583,663 |
| Profits Per Employee | $76,917 |
| Employee Count | 7,070 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 2.34 |
Taxes
In the past 12 months, Hologic has paid $119.60 million in taxes.
| Income Tax | 119.60M |
| Effective Tax Rate | 18.03% |
Stock Price Statistics
The stock price has increased by +2.76% in the last 52 weeks. The beta is 0.73, so Hologic's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | +2.76% |
| 50-Day Moving Average | 74.88 |
| 200-Day Moving Average | 68.15 |
| Relative Strength Index (RSI) | 48.70 |
| Average Volume (20 Days) | 2,651,761 |
Short Selling Information
The latest short interest is 3.79 million, so 1.70% of the outstanding shares have been sold short.
| Short Interest | 3.79M |
| Short Previous Month | 3.75M |
| Short % of Shares Out | 1.70% |
| Short % of Float | 1.71% |
| Short Ratio (days to cover) | 1.39 |
Income Statement
In the last 12 months, Hologic had revenue of $4.13 billion and earned $543.80 million in profits. Earnings per share was $2.40.
| Revenue | 4.13B |
| Gross Profit | 2.49B |
| Operating Income | 1.07B |
| Pretax Income | 663.40M |
| Net Income | 543.80M |
| EBITDA | 1.35B |
| EBIT | 1.07B |
| Earnings Per Share (EPS) | $2.40 |
Balance Sheet
The company has $2.37 billion in cash and $2.52 billion in debt, with a net cash position of -$153.70 million or -$0.69 per share.
| Cash & Cash Equivalents | 2.37B |
| Total Debt | 2.52B |
| Net Cash | -153.70M |
| Net Cash Per Share | -$0.69 |
| Equity (Book Value) | 5.25B |
| Book Value Per Share | 23.51 |
| Working Capital | 2.89B |
Cash Flow
In the last 12 months, operating cash flow was $1.10 billion and capital expenditures -$140.50 million, giving a free cash flow of $957.20 million.
| Operating Cash Flow | 1.10B |
| Capital Expenditures | -140.50M |
| Free Cash Flow | 957.20M |
| FCF Per Share | $4.29 |
Margins
Gross margin is 60.38%, with operating and profit margins of 25.81% and 13.18%.
| Gross Margin | 60.38% |
| Operating Margin | 25.81% |
| Pretax Margin | 16.08% |
| Profit Margin | 13.18% |
| EBITDA Margin | 32.73% |
| EBIT Margin | 25.81% |
| FCF Margin | 23.20% |
Dividends & Yields
Hologic does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.04% |
| Shareholder Yield | 4.04% |
| Earnings Yield | 3.26% |
| FCF Yield | 5.73% |
Analyst Forecast
The average price target for Hologic is $77.89, which is 4.12% higher than the current price. The consensus rating is "Hold".
| Price Target | $77.89 |
| Price Target Difference | 4.12% |
| Analyst Consensus | Hold |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 5.42% |
| EPS Growth Forecast (5Y) | 23.75% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 3, 2008. It was a forward split with a ratio of 2:1.
| Last Split Date | Apr 3, 2008 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Hologic has an Altman Z-Score of 4.02 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.02 |
| Piotroski F-Score | 5 |